GLP-1S 10mg

$259.00

Semaglutide is a powerful GLP-1 receptor agonist designed for the effective management of type 2 diabetes and long-term weight loss. With 94% structural similarity to the naturally occurring human GLP-1 hormone, this synthetic peptide works by replicating the hormone’s key functions. Semaglutide helps regulate blood sugar levels and reduces appetite, making it an ideal option for those seeking sustained weight control and metabolic balance.

Description

Referenced Citations

  1. Jastreboff, A.M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. [Online].
    Available: https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
  2. Marso, S.P., et al. (2016). GLP-1 and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med, 375(19), 1834-1844. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/27633186/
  3. Bachem. (2024). GLP-1 Peptide API Manufacturer & Supply. [Online].
    Available: https://www.bachem.com/all-generic-apis/semaglutide/
  4. Smits, M.M., and Van Raalte, D.H. (2021). Safety of GLP-1. Front Endocrinol, 12, 1-19. [Online].
    Available: https://www.frontiersin.org/articles/10.3389/fendo.2021.645563/full
  5. Aroda, V.R., et al. (2019). PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral GLP-1 Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes. Diabetes Care, 42(9), 1724-1732. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/31186300/